It's one of the top healthcare stocks in my portfolio. If I didn't already own this biotech stock, I wouldn't hesitate to buy ...

The company also announced plans to proceed with a Phase 3 trial for suzetrigine, a decision that has left some analysts questioning the rationale. One commentator stated on X "Vertex often gets the ...